Zobrazeno 1 - 10
of 10
pro vyhledávání: '"G R Saraswathy"'
Autor:
G Divyashri, T P Krishna Murthy, Subramaniam Sundareshan, Pavan Kamath, Manikanta Murahari, G R Saraswathy, Bindu Sadanandan
Publikováno v:
BioImpacts, Vol 11, Iss 2, Pp 119-127 (2021)
Introduction: The present study attempts to identify potential targets of H. pylori for novel inhibitors from therapeutic herb, mango ginger (Curcuma amada Roxb.). Methods: Crystal structure of all the selected drug targets obtained from Protein Data
Externí odkaz:
https://doaj.org/article/edad4e728e5c41c981a701e63122a004
Publikováno v:
Indian Journal of Psychological Medicine, Vol 37, Iss 3, Pp 355-357 (2015)
Varenicline is a smoking cessation agent. Varenicline acts as a partial agonist of α4β2 neuronal nicotinic acetylcholine receptor and prevents nicotine binding to the same. It also causes dopamine (DA) stimulation that decreases craving and symptom
Externí odkaz:
https://doaj.org/article/9b9beabcf5084e51889cce31ea559a12
Publikováno v:
Journal of Oral Pathology & Medicine. 49:926-932
Background Oral lichen planus (OLP) is a chronic T cell-mediated, immunological, mucocutaneous disease with a number of genes and inflammatory mediators implicated in its pathogenesis. Heart shock protein 70 and the proinflammatory mediator TNFα hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774c6dbff3cab0fe3733980ffa37ae9e
https://doi.org/10.1111/jop.13100
https://doi.org/10.1111/jop.13100
Publikováno v:
Conference on Drug Design and Discovery Technologies ISBN: 9781788018623
Multiple sclerosis (MS) is a multifocal demyelinating disease with progressive neurodegeneration caused by an increased auto immune response to self-antigens. Based on the ability of remyelination, MS is characterized into 4 subtypes: Relapsing Remit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ffc28a07478df200f05f03d92e0f1a2
https://doi.org/10.1039/9781839160783-00079
https://doi.org/10.1039/9781839160783-00079
Publikováno v:
Conference on Drug Design and Discovery Technologies ISBN: 9781788018623
Huntington’s Disease (HD), a fatal neurodegenerative disorder, is an autosomal dominant condition characterized by improper involuntary movements of the voluntary muscles (chorea), dystonia, difficulty in speech and cognitive impairment along with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::957207d8bbfa215c3fa066f2188e5342
https://doi.org/10.1039/9781839160783-00069
https://doi.org/10.1039/9781839160783-00069
Publikováno v:
Annals of Oncology. 32:S19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31bf006ba0cb7d80082ded638df5fd43
https://doi.org/10.1016/j.annonc.2021.01.063
https://doi.org/10.1016/j.annonc.2021.01.063
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss, Pp 700-716 (2019)
Drug repurposing is an unconventional drug discovery approach to explore new therapeutic benefits of existing, shelved and the drugs in clinical trials. This approach is currently emerging to overcome the bottleneck constraints faced during tradition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ba8b7485340501eea8574c19a2ec90
https://pubmed.ncbi.nlm.nih.gov/30553197
https://pubmed.ncbi.nlm.nih.gov/30553197
Publikováno v:
Indian Journal of Psychological Medicine, Vol 37, Iss 3, Pp 355-357 (2015)
Indian Journal of Psychological Medicine
Indian Journal of Psychological Medicine
Varenicline is a smoking cessation agent. Varenicline acts as a partial agonist of α4β2 neuronal nicotinic acetylcholine receptor and prevents nicotine binding to the same. It also causes dopamine (DA) stimulation that decreases craving and symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3bffda8b7a259cdf6af5be7be42cb5
http://www.ijpm.info/article.asp?issn=0253-7176
http://www.ijpm.info/article.asp?issn=0253-7176
Publikováno v:
Journal of Molecular Biomarkers & Diagnosis.
A 27 year old male diagnosed with psychosis, who was treated with Risperidone followed by aripiprazole was reported to present with adverse effects. Hence the therapy was changed to Blonanserin. It is a dopamine serotonin antagonist which has got few
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e4390743bb4da95925a47ba88f81e0f
https://doi.org/10.4172/2155-9929.1000254
https://doi.org/10.4172/2155-9929.1000254